H1B Report
H-1B sponsorNJFEIN 22-1734359Updated Jul 2026

Teva Pharmaceuticals USA, Inc.

US H-1B Labor Condition Application activity for Teva Pharmaceuticals USA, Inc.. Filed 340 disclosures between FY2010 and FY2026 from worksites with a NJ headquarters indicator.

Total filings
5
Outside top-N · FY2026
Certified
100.0%
unconditional · FY2026
Withdrawn
0.0%
withdrawn rate · FY2026
Denied
0.0%
rejection rate · FY2026

H-1B outcome breakdown

Share of Teva Pharmaceuticals USA, Inc.’s LCAs by DOL case status, all fiscal years. Use the year filter above for a single-year breakdown.

Outcome breakdown: Certified 80.0%, Cert-withdrawn 12.9%, Withdrawn 6.2%, Denied 0.9%
Outcome breakdown
OutcomeShare
Certified80.0%
Cert-withdrawn12.9%
Withdrawn6.2%
Denied0.9%
Certified80.0%
Cert-withdrawn12.9%
Withdrawn6.2%
Denied0.9%

Top occupations sponsored

SOC codes filed most by Teva Pharmaceuticals USA, Inc. across all fiscal years. Click any row to open the national salary guide.

H-1B filings by fiscal year

Year-over-year H-1B filing volume — a hiring-demand signal, not headcount.

YearFilings
FY201010
FY201110
FY201228
FY201311
FY201417
FY201534
FY201630
FY201751
FY201865
FY201940
FY20205
FY202113
FY20228
FY20232
FY20244
FY20257
FY20265
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY201010
FY201110
FY201228
FY201311
FY201417
FY201534
FY201630
FY201751
FY201865
FY201940
FY20205
FY202113
FY20228
FY20232
FY20244
FY20257
FY20265
Compare Teva Pharmaceuticals USA, Inc. with another sponsor
Side-by-side view of KPIs, outcomes, top breakdowns and yearly trend.
Popular comparisons
Explore by rank
Pre-built leaderboards for the most-asked questions.